Universal Health International Group Holding Ltd
02211
Company Profile
Business description
Universal Health International Group Holding Ltd distributes and retails pharmaceutical products in Northeast China. The company operates its business through two segments: pharmaceutical retail and Distribution, (including import and export trade) include prescribed drugs, non-prescribed drugs (Chinese patent medicines, chemical preparations, antibiotics and biochemical drugs), traditional Chinese medicine decoction pieces, biological products, protein assimilation preparations, peptide hormones, blood products, disinfection products, medical equipment, etc. and majority of revnue comes from Distribution segment.
Contact
No. 14-1, Bei Yi Zhong Road
Tiexi District
Liaoning Province
Shenyang
CHNSector
Healthcare
Stock type
Defensive
Industry
Pharmaceutical Retailers
Fiscal Year End
30 June 2026
Employees
665
Stocks News & Analysis
stocks
Jet fuel price spike weighing on Australian airline profits
Fuel volatility can lead to short-term earnings swings but all players bear the cost almost equally.
stocks
US utilities stocks keep rallying as investors bet on power demand growth
Rising electricity demand from data centers supports earnings growth, but Morningstar analysts say the sector looks less attractive after a sharp rally.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,173.60 | 49.60 | -0.54% |
| CAC 40 | 8,262.70 | 11.87 | -0.14% |
| DAX 40 | 24,154.47 | 87.77 | 0.36% |
| Dow JONES (US) | 48,578.72 | 115.00 | 0.24% |
| FTSE 100 | 10,589.99 | 30.41 | 0.29% |
| HKSE | 26,394.26 | 446.94 | 1.72% |
| NASDAQ | 24,102.70 | 86.69 | 0.36% |
| Nikkei 225 | 59,518.34 | 1,384.10 | 2.38% |
| NZX 50 Index | 13,066.06 | 10.52 | -0.08% |
| S&P 500 | 7,041.28 | 18.33 | 0.26% |
| S&P/ASX 200 | 8,955.00 | 62.20 | -0.69% |
| SSE Composite Index | 4,055.55 | 28.34 | 0.70% |